Journey Medical (DERM) Non Operating Income (2020 - 2026)

Journey Medical (DERM) has reported Non Operating Income for 7 consecutive years, with -$753000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non Operating Income rose 12.44% year-over-year to -$753000.0; the trailing twelve-month figure through Jun 2026 stood at -$3.1 million (down 75.36% YoY), and the FY2025 full-year result was -$3.2 million, down 242.51% from the prior year.
• Non Operating Income declined to -$753000.0 in Q2 2026 per DERM's latest filing, from -$738000.0 in the prior quarter.
• Across five years, Non Operating Income topped out at $504000.0 in Q3 2024 and bottomed at -$860000.0 in Q2 2025.
• Historically, Non Operating Income has averaged -$512833.3 across 5 years, with a median of -$606000.0 in 2022.
• The widest YoY moves for Non Operating Income: up 239.61% in 2024, down 849.43% in 2024.
• Over 5 years, Non Operating Income stood at -$634000.0 in 2022, then soared by 113.72% to $87000.0 in 2023, then plunged by 849.43% to -$652000.0 in 2024, then slipped by 23.31% to -$804000.0 in 2025, then climbed by 6.34% to -$753000.0 in 2026.
• According to Business Quant data, Non Operating Income over the past three periods registered -$753000.0, -$738000.0, and -$804000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.